Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kuwata

Showing results (191-200 of 192) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 192 results.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancerD Okemoto, I Nakayama, A Jubashi, et al.
ESMO Open|October 1, 2025
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancerK Yamamoto, Y Owaki, I Nakayama, et al.
Pageof 20

Showing results (191-200 of 192) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 192 results.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancerD Okemoto, I Nakayama, A Jubashi, et al.
ESMO Open|October 1, 2025
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancerK Yamamoto, Y Owaki, I Nakayama, et al.
Pageof 20